Want to see SE:SUBGEN full AI Analyst Report?

AegirBio AB (SUBGEN) Cash flow

1 Followers

AegirBio AB Cash Flow

SE:SUBGEN's free cash flow for Q2 2026 was kr-7.74M. For the 2026 fiscal year, SE:SUBGEN's free cash flow was decreased by kr-8.01M and operating cash flow was kr-9.00M. See a summary of the company’s cash flow.

Cash Flow	Mar 26	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	kr -12.56M	kr -12.57M	kr -41.99M	kr -49.00M	kr -109.37M
Investing Cash Flow	kr -66.47M	kr -15.55M	kr -5.54M	kr -65.00K	kr 1.60M
Financing Cash Flow	kr 89.26M	kr 16.24M	kr 45.05M	kr 29.26M	kr 130.25M
End Cash Position	kr 18.74M	kr 283.00K	kr 12.14M	kr 14.59M	kr 34.03M
Free Cash Flow	kr -20.59M	kr -12.58M	kr -47.52M	kr -49.06M	kr -109.37M

Currency in SEK